The present application provides a chimeric antigen receptor (CAR) capable ofspecificallybinding to the BCMA protein, which contains a BCMA-binding domain, atransmembrane domain,a costimulatory domain and an intracellular signal transduction domain. Thepresent applicationalso provides an application of the CAR in treating diseases or conditionsassociated with theexpression of BCMA.